TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Evaxion Biotech A/S
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
68
|
0
![]() |
0 |
Earnings before taxes |
-21,188
|
-22,833
|
-21,572 |
Total assets |
12,407
|
20,230
|
35,369 |
Current assets |
7,527
|
14,885
|
29,935 |
Current liabilities |
7,152
|
3,107
|
3,746 |
Equity capital |
-4,279
|
7,785
|
28,619 |
- share capital |
5,085
|
3,246
|
3,120 |
Employees (average) |
35
![]() |
35
![]() |
35 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
-34.5%
|
38.5%
|
80.9% |
Turnover per employee |
2
|
0
![]() |
0 |
Profit as a percentage of turnover | -31158.8% | ||
Return on assets (ROA) | |||
Current ratio |
105.2%
|
479.1%
|
799.1% |
Return on equity (ROE) |
495.2%
|
-293.3%
|
-75.4% |
Change turnover |
68
|
0
![]() |
0 |
Change turnover % | |||
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.